Oxford BioDynamics and Kings College London to advance rheumatoid arthritis treatment

cafead

Administrator
Staff member
  • cafead   May 16, 2024 at 11:42: AM
via Oxford BioDynamics (OBD) and King's College London (KCL) have partnered to use OBD's EpiSwitch technology to identify patients at risk of rheumatoid arthritis (RA) who can benefit from abatacept treatment.

article source
 

<